Gilead Sciences: Last News

US buys up virtually the entire production of Covid-19 drug Remdesivir for the next three months

The US government has bought virtually the entire production of the Covid-19 drug Remdesivir for the next three months.

The US Department of Health & Human Services has reached an agreement with the drug's manufacturer, Gilead Sciences, to purchase all its projected production for this month and 90% of production in August and September.

This will make the drug unavailable to Europe and most of the rest of the world.

Remdesivir is expected to be in high demand as one of the only treatments shown to alter the course of Covid-19.

After the intravenously administered medicine helped shorten hospital recovery times in a clinical trial, it won emergency use authorisation in the United States and full approval in Japan.

For US patients with

News World

Gilead Sciences Coronavirus

Related News

Breaking news
Lawmakers vote closes down Philippines' largest TV network
Guelph, Ont. long-term care worker tests positive for coronavirus
(VIDEO) Ex-OIC of the PNB obstructs the duties of a photo-journalist